Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin in type 2 diabetes mellitus
NCT00642278Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Apr 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 13
01
Overview
Phase 2, randomised, double-blind trial of canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Johnson & Johnson. Started Apr 2008; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00642278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642278.